Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-03-21 @ 7:59 PM
Study NCT ID:
NCT01305135
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2011-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GFM-AZA-IDA-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None